Announcements Trials
Browse Landscape

Phase

Phase 1 12Phase 1/2 8Phase NA 7Phase 2 3Phase 3 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 40Recruiting 22Unknown 15Terminated 12Withdrawn 11Not yet recruiting 8Active not recruiting 6Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, B-Cell 2Colorectal Neoplasms 2Pancreatic Ductal Adenocarcinoma 1Ototoxicity 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Leukemia, B-Cell 1Hepatoblastoma 1Depression 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Anxiety Disorders 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Suspended × Neoplasms × Clear all
NCT06213298 2026-02-11

Effect of Kava on Anxiety and Stress in Cancer Survivors

Masonic Cancer Center, University of Minnesota

Phase EARLY_PHASE1 Suspended
43 enrolled

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡